HealthEquity, Inc.

HealthEquity, Inc. (HQY) Market Cap

HealthEquity, Inc. has a market capitalization of $8.41B.

Price: $100.61

-0.38 (-0.38%)

Market Cap: 8.41B

NASDAQ · time unavailable

CEO: Scott R. Cutler

Sector: Healthcare

Industry: Medical - Healthcare Information Services

IPO Date: 2014-07-31

Website: https://www.healthequity.com

HealthEquity, Inc. (HQY) - Company Information

Market Cap: 8.41B|Sector: Healthcare

Company Profile

Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.

Analyst Sentiment

84%
Strong Buy

From 16 Active Polls

1Y Forecast: $108.38

▲ +7.7% Potential Upside

Consensus Target Metrics

Low Bound

$100

Median

$109

High Bound

$115

Average

$108

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$108.38
▲ +7.72% Upside
Low Target
$100.00
-1% Risk
Median Target
$109.00
8% Mid
High Target
$115.00
14% Max
Consensus
Buy
25 / 27 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MApr 30, 2026Jan 31, 2026Oct 31, 2025Jul 31, 2025Apr 30, 2025Jan 31, 2025Oct 31, 2024Jul 31, 2024
Market Cap ($M)8,4116,9247,3798,1338,3957,4289,5737,4336,838
Enterprise Value ($M)9,1317,6448,0618,8529,1468,24710,3868,2467,669
Price to Earnings Ratio (P/E)37.2625.0136.3039.4135.1434.5692.02325.8847.85
Price/Earnings-to-Growth Ratio (PEG)4.179.415.6624.281939.2911.16
Price to Sales Ratio (P/S)6.2919.5322.0525.2525.7722.4530.7024.7422.80
Price to Book Ratio (P/B)4.153.383.503.813.913.504.533.503.17
Price to Free Cash Flow Ratio (P/FCF)17.2571.2772.6859.0355.54152.86153.9395.68-67.73
Enterprise Value to Sales (EV/Sales)21.5524.0927.4828.0724.9333.3127.4525.57
Enterprise Value to EBITDA (EV/EBITDA)19.9172.1480.0273.5569.5766.21123.05126.6872.58
Debt to Equity Ratio1.570.480.480.480.490.520.520.530.54

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HEALTHEQUITY INC (HQY) — Investment Overview

🧩 Business Model Overview

HEALTHEQUITY INC administers health savings accounts (HSAs) and related consumer-directed healthcare benefits for employers, plan administrators, and financial institution partners. The value chain centers on (1) enrolling individuals into tax-advantaged accounts, (2) managing account servicing and compliance, and (3) enabling benefit spending through integrated debit/processing services and digital tools.

Revenue is driven by the growth and ongoing servicing of account balances and transactions—creating customer stickiness as account holders and employers rely on an established platform for funding, rules-based eligibility, contributions, and payment execution.

💰 Revenue Streams & Monetisation Model

HQY’s monetisation model combines recurring account administration economics with transaction and servicing fees:

  • Recurring account servicing and administration fees: Contracted or per-account economics tied to maintaining HSA relationships.
  • Payment and spend-related fees: Revenue tied to debit/processing and card usage and associated service features.
  • Investment/“float”-like economics: Benefits from HSA cash flows and balances that can be invested, subject to applicable regulatory and risk management constraints.

Margin drivers typically include (1) growth in net funded balances and contribution volume, (2) operating leverage from servicing scale, (3) fee take rates on account and payment activity, and (4) economics of invested balances (net of funding costs, credit exposure, and regulatory constraints).

🧠 Competitive Advantages & Market Positioning

HQY’s moat is best characterized as a combination of high switching costs (data and operational integration) and regulatory/service barriers (complexity of HSA administration and compliance), reinforced by an integrated ecosystem across account servicing and spending.

  • Switching costs / data gravity: Employers and account holders benefit from established workflows (contributions, eligibility handling, reporting, and spend experiences). Moving accounts can be operationally burdensome due to compliance timelines, data migration, and process reconfiguration.
  • High-barriers service capability: Accurate, compliant administration at scale is difficult to replicate without deep systems, controls, and operational expertise.
  • Integrated ecosystem: Bundling account administration with payment enablement supports cross-sell of services and improves retention.

COMPETITIVE BENCHMARKING: Primary competitors include Optum Bank (UnitedHealth), Fidelity, and U.S. Bank / PayFlex (among other benefits administrators and banking partners).

Industry focus contrast: While large financial institutions and insurers often distribute HSAs as part of broader financial or healthcare offerings, HQY’s positioning emphasizes dedicated consumer-directed healthcare administration plus payment enablement—supporting a more product-specialized platform. This specialization can matter where employers and partners want a high-throughput, technology-led administration and spend experience with consistent compliance tooling.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, the opportunity set is supported by structural adoption of consumer-directed healthcare:

  • HDHP penetration and HSA adoption: As employers and individuals shift toward high-deductible plan designs, HSAs become a primary savings and spending vehicle.
  • Tax-advantaged compounding incentives: The HSA’s favorable tax treatment creates durable demand for account longevity and ongoing contributions.
  • Transaction and digital spend expansion: Increased card usage, digital onboarding, and payroll contribution workflows can lift monetisation per participant over time.
  • Partner channel development: Growth via employer relationships and financial institution partners supports account inflows without solely relying on direct-to-consumer acquisition.

The long-term growth thesis rests on building a larger installed base and deepening economics per account through servicing, spend enablement, and value-added tools—while leveraging operating scale.

⚠ Risk Factors to Monitor

  • Regulatory risk to HSA rules: Changes to contribution limits, eligibility, qualified expense definitions, or administrative requirements can alter customer behavior and account economics.
  • Investment/balance economics volatility: The economics tied to invested HSA balances can be sensitive to interest rate conditions, market spreads, liquidity requirements, and risk constraints.
  • Competitive pricing and partner deal pressure: Large incumbents may compete aggressively on fees, bundled benefits administration, or banking services, pressuring take rates.
  • Operational and security risk: As a custodian-like administrator for sensitive financial and health-related data, cyber risk and operational failures can damage trust and retention.
  • Credit and fraud controls: Payment and spend-related fraud management and underwriting controls must remain robust to protect unit economics.

📊 Valuation & Market View

Market participants typically value this category using a blend of revenue quality metrics (recurring fee base), installed base growth (account and balance growth), and cash generation sensitivity (including investment spread/float-like economics, where applicable).

Key valuation drivers commonly include:

  • Account growth and net funded balances: Sustained inflows improve servicing economics and investment-related earnings power.
  • Fee mix and operating leverage: Higher contribution and spend activity can support margin progression.
  • Retention and churn: Durable relationships reduce unit volatility.
  • Regulatory and balance-economics outlook: Expectations for HSA administrative and investment rules affect risk-adjusted returns.

🔍 Investment Takeaway

HEALTHEQUITY INC presents an institutional long-term thesis anchored in a specialized consumer-directed healthcare administration platform, where switching costs, compliance-driven barriers, and integrated account-and-spend capabilities support durability of the customer base. Multi-year growth is tied to structural expansion in HDHP and HSA adoption, with upside from deeper monetisation via transaction enablement and operating scale. The primary underwriting focus should remain on regulatory durability and the stability of balance-investment economics.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HQY.

defenseworld.net2026-07-28

Castleark Management LLC Purchases New Position in HealthEquity, Inc. $HQY

Castleark Management LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ: HQY) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 48,510 shares of the company's stock, valued at approximately $4,054,000. Castleark Management LLC owned approximately

seekingalpha.com2026-07-27

HealthEquity's Earnings Momentum Deserves More Credit

HealthEquity is the leading HSA and CDB administrator, consistently beating revenue and EPS expectations with strong operational execution. HQY's fiscal 2027 revenue is guided to $1.41–$1.42 billion, with robust HSA asset growth, margin expansion, and accelerating buybacks supporting a Buy rating. Custodial yield remains resilient at 3.84%, supported by rate locks through 2029, while automation and AI investments drive significant cost efficiencies.

defenseworld.net2026-07-25

Bank of New York Mellon Corp Lowers Position in HealthEquity, Inc. $HQY

Bank of New York Mellon Corp trimmed its position in HealthEquity, Inc. (NASDAQ: HQY) by 3.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 599,254 shares of the company's stock after selling 22,625 shares during the quarter. Bank of New York Mellon

zacks.com2026-07-23

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

defenseworld.net2026-07-21

Allspring Global Investments Holdings LLC Lowers Position in HealthEquity, Inc. $HQY

Allspring Global Investments Holdings LLC trimmed its position in shares of HealthEquity, Inc. (NASDAQ: HQY) by 63.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 266,615 shares of the company's stock after selling 462,895 shares during the

zacks.com2026-07-16

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.

zacks.com2026-07-13

Here's Why HealthEquity (HQY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com2026-07-08

GDRX or HQY: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com2026-07-06

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com2026-06-19

Here's Why HealthEquity (HQY) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com2026-06-12

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.

zacks.com2026-06-11

Is HealthEquity's Improving Profitability Enough to Offset Key Risks?

HQY raises fiscal 2027 guidance after strong Q1 results, but custodial yield swings and cybersecurity worries remain.

globenewswire.com2026-06-08

One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds

Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control

zacks.com2026-06-08

3 Medical Service Industry Stocks Thriving Amid Workforce Challenges

BTSG, BDSX and HQY stand to benefit as digital health, healthcare analytics and nursing care growth offset workforce strains.

zacks.com2026-06-04

3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-04-30

"HQY reported Q1’27 Revenue of $354.6M (+7.2% QoQ from $334.6M; +7.2% YoY from $330.8M). Net Income was $69.4M (+39.5% QoQ from $49.7M; +28.7% YoY from $53.9M) and EPS rose to $0.82. Profitability strengthened across the quarter: net margin improved to 19.6% from 14.9% in Q4, and gross margin expanded to 72.3% versus 92.4% in Q4 (noting Q4’s unusually high gross margin), while operating margin improved to 29.0% from 20.1%. Cash flow remained strong but volatile: operating cash flow was $97.5M (QoQ below Q4’s $117.9M, but above Q1’26’s $64.7M). Free cash flow was $97.2M, and the company continued heavy capital return via buybacks (-$123.3M in the quarter). Balance sheet resilience appears solid for a non-bank: cash and cash equivalents were $265.4M and net debt was negative (-$223.3M), indicating net cash. Equity was stable at ~$2.05B. On total shareholder returns, the stock price was $86.04 with only +4.3% over the last year (below a 20% momentum threshold). Dividend paid was $0, so returns are primarily from buybacks/valuation. Analyst valuation context: consensus price target is $109.89 vs. $86.04 current (~+27.7% upside)."

Revenue Growth

Positive

Revenue grew +7.2% QoQ (to $354.6M) and +7.2% YoY (vs. $330.8M), indicating steady top-line momentum.

Profitability

Good

Net income rose +39.5% QoQ and +28.7% YoY. Net margin expanded to 19.6% (from 14.9% in Q4). Operating margin improved to 29.0% (from 20.1% in Q4).

Cash Flow Quality

Positive

Operating cash flow was $97.5M and free cash flow $97.2M. Continued large buybacks (-$123.3M) with no dividends, supporting shareholder returns but increasing cash outflow variability.

Leverage & Balance Sheet

Good

Net debt is negative (-$223.3M) and liquidity is strong (cash $265.4M). Total equity is stable around ~$2.05B, suggesting balance-sheet resilience.

Shareholder Returns

Neutral

No dividend; buybacks are the key return mechanism. Price momentum was modest: +4.3% 1Y, below the >20% momentum threshold.

Analyst Sentiment & Valuation

Positive

Consensus target $109.89 vs. $86.04 current implies ~+27.7% upside, signaling constructive sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

HealthEquity delivered strong Q1 profitability with clear bps-driven margin expansion (gross margin +400 bps to 72%, adjusted EBITDA margin +400 bps to 46%) alongside disciplined capital allocation (accelerated $123m repurchase and +$1b authorization). Growth was powered by the compounding HSA flywheel: HSA assets +19% and new HSAs +15% (172k), plus engagement acceleration via Mark and digital usage (mobile MAUs +90%, >2/3 marketplace transactions on mobile). Management’s AI narrative was financially tangible: fraud reimbursements dropped from ~$3.2m to ~$0.3m and AI automation reduced manual handling of key workflows by >90%, cutting card contacts by >50k and improving fraud metrics below target. Fiscal 27 guidance was raised with revenue $1.41b–$1.42b and adjusted EBITDA $625m–$633m, plus an average HSA cash yield of ~3.85% backed by forward rate locks. Key diligence point: service cost beat appears utilization-driven and expected to partially reverse.

AI IconGrowth Catalysts

  • Total HSA assets +19% YoY; new HSAs +15% YoY (172k new HSAs) and total HSA growth +8%, outperforming Devenir’s reported 6% market growth for CY2025
  • Engagement flywheel via Mark: >10k+ members accessing health programs; expanded Mark into diagnostics and men’s health to drive marketplace conversion
  • Investing momentum: HSA investors +18% YoY; invested assets held by members +38% YoY, supported by low industry penetration (~10% using full investing tax benefits)
  • Digital activation: mobile monthly active usage +90% YoY; >2/3 of marketplace transactions via mobile app

Business Development

  • Depository partner exited a custodial cash contract early, contributing a one-time breakage fee (impacting HSA cash yield) and indicating ongoing contract re-optimizations
  • Marketplace program expansion: added TRT and diagnostics and men’s health; no explicit new external partner names provided in the excerpt

AI IconFinancial Highlights

  • Revenue +7% YoY; Service revenue record $123m (+3% YoY) supported by marketplace activity; Custodial revenue record $174m (+11% YoY)
  • Adjusted EBITDA margin expanded to 46% vs 42% prior-year quarter (+400 bps) with Adjusted EBITDA $165m (+17% YoY)
  • Gross profit margin improved to 72% vs 68% (+400 bps) YoY
  • GAAP EPS $0.82; non-GAAP EPS $1.24 (diluted) vs internal expectations not stated in transcript
  • Annualized yield on HSA cash 3.84%; excluding one-time breakage fee yield would have been 3.78% (one-time uplift)
  • Service costs: fraud reimbursements ~ $0.3m vs ~$3.2m YoY prior period; fraud cost declined nearly 90% YoY; service efficiency improvements supported by AI automation
  • Q1 fraud reimbursements and contact reductions attributed to improved fraud prevention/detection and secure mobile tools; AI reduced manual handling of service emails by 25% and claims/card workflows by >90% manual effort with processing accelerated up to 50%

AI IconCapital Funding

  • Share repurchase: accelerated repurchase of $123m during the quarter; board increased share repurchase authorization by $1.0b
  • Balance sheet: cash $265m at quarter end; operating cash flow $98m during the quarter
  • Debt outstanding: ~$943m net of issuance costs
  • Guidance commentary: potential revolver reductions during fiscal 27; expectation to remain an active share buyer while preserving revolver availability for portfolio acquisitions

AI IconStrategy & Ops

  • AI as an “operational amplifier”: reduced manual handling of member/client service emails by 25%; targeted workflows (card servicing and claims inquiries) reduced manual efforts by >90%; accelerated processing by up to 50%
  • Reduced card-related service center contacts by >50k via AI-enabled self-service/automation
  • Fraud metrics: fraud remained below target; card acceptance improved; fraud cost declined nearly 90% YoY
  • Digital product strategy: single AI/personalized app as the long-term conduit for self-service, education, and marketplace engagement (app features cited: push-button card activation)
  • Self-service and automation expansion emphasized as the primary driver of service cost per account improvements

AI IconMarket Outlook

  • Fiscal 27 raised guidance (as provided): Revenue $1.41b–$1.42b; GAAP net income $242m–$248m ($2.88–$2.95 per share); Non-GAAP net income $292m–$398m ($4.66–$4.73 per share) (shares assumed 84m for the year
  • Adjusted EBITDA guidance $625m–$633m
  • Average yield on HSA cash expected ~3.85% during fiscal 27 (with rate-lock/forward treasury contracts cited to reduce volatility)

AI IconRisks & Headwinds

  • Healthcare utilization and medical claims variability: management noted internal utilization beats expectations due to lower medical claim usage; guided assumption may mean cost will “come back” and therefore beat was pushed into the forecast rather than banking on continued favorable utilization
  • AI cost risk: AI compute/token usage can increase tech/dev costs; management expects to keep spend within an overall tech/dev envelope while still driving operating efficiency
  • Market growth concentration: HSA category growth described as “winner-take-most” with top players capturing disproportionate growth; competitive pressure implied for ongoing market-share capture
  • Marketplace economics not yet broken out; reliance on continued engagement-to-transaction conversion for marketplace growth durability

Q&A: Analyst Interest

  • Mark marketplace gating and go-to-market design: Management said there’s no marketing-spend gating; growth starts with member engagement. Q1 focused on scaling foundations (visibility, MarkTech capabilities, new programs TRT and diagnostics). Conversion depends on driving mobile monthly active users and then exposing members to marketplace.
  • AI’s expense-to-savings mechanics: Analysts asked whether AI investment should reduce tech/development costs, given cap/software growth. Management acknowledged token/compute costs could rise but emphasized they’re kept within a revenue-linked tech/dev spend envelope. Major savings came via reduced manual resolution time (up to 90%) and automation in targeted service journeys.
  • Service cost bridge and utilization assumptions: Management addressed YoY service cost improvement and whether it was one-time. They cited medical claim usage below expectations, pushing the beat into the forecast. They expect costs to normalize, describing it as seasonal/marketwide with no change to payer/corporate clients’ medical utilization assumptions.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the HQY Q1 2027 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HQY.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (HQY)

© 2026 Stock Market Info — HealthEquity, Inc. (HQY) Financial Profile